Table.
Patient No | Captopril group
|
Control group
|
|||||
---|---|---|---|---|---|---|---|
Baseline | 8 Years | 8 Years + pause | Baseline | 8 Years | 8 Years + pause | ||
1 | 100 | 101 | 120 | 141 | 157* | 135* | |
2 | 129 | 125 | 131 | 156 | 131 | — | |
3 | 153 | — | — | 131 | 123 | — | |
4 | 96 | 75 | — | 96 | 39* | 47* | |
5 | 114 | 99 | 122* | 87 | 84 | — | |
6 | 112 | 98 | 116* | 132 | 106* | — | |
7 | 105 | 105* | 112* | 154 | 68* | — | |
8 | 127 | 145* | 140* | 151 | 143 | — | |
9 | 140 | 127 | 144 | 150 | 161 | — | |
10 | 108 | 70 | 102* | 117 | 106 | — | |
11 | 169 | — | — | 111 | — | — | |
12 | 144 | 120 | 121 | 148 | 144 | — | |
13 | 117 | 104 | — | 118 | 119 | — | |
14 | 110 | 100 | 97 | 108 | 94* | — | |
15 | 96 | 108 | — | 126 | 141 | — | |
16 | 171 | 151 | 166 | 142 | 168 | — | |
17 | 164 | 156 | 161* | 145 | 130 | — | |
18 | 128 | 106 | 103 | 146 | 140 | — | |
19 | 104 | 116 | 105 | 122 | —* | — | |
20 | 130 | 135 | 146 | 117 | 91* | — | |
21 | 132 | 122 | 128 | 120 | 112* | — | |
22 | — | — | — | 136 | 130* | — | |
23 | — | — | — | 120 | 118 | — | |
Mean(SD) | 126 (24) | 114 (23) | 126 (21) | 129 (18) | 119 (32)† | — |
Patient developed diabetic nephropathy during 8 years of follow up or during treatment pause.
Difference from baseline significant at P=0.03.